Mayne Pharma | MYX - 市值



金融业
股票价格
AUD 2.54
资产
AUD 1.14B
现金及等价物
AUD 110.07M
销售成本
AUD 43.74M
流动资产
AUD 460.59M
流动负债
AUD 313.94M
债务
AUD 38.82M
EBIT
AUD -16.2M
EBITDA
AUD 20.9M
员工
450
EPS每股收益
AUD 0.31
股本和储备
AUD 454.19M
销售毛利
AUD 86.13M
债务利息支出
AUD 1.2M
贷款资金
AUD 2.66M
市值
AUD 216.09M
净收入
AUD -103.68M
营业费用
AUD 103.54M
营业利润
AUD -3.3M
普通股股本
AUD 81.25M
税前利润
AUD -14.7M
销售收入
AUD 86.5M
销售和管理费用
AUD 54.8M
股票
AUD 74.63M
贸易债权人
AUD 30.25M
应收帐款人
AUD 193.22M


市值 更改 日
Ansell USD 3.36B 450.92M 2025-12
Avita Medical AUD 105.47M 35.32M 2025-12
Cochlear AUD 17.05B 2.6B 2025-12
CSL USD 55.89B 20.42B 2025-12
Integral Diagnostics AUD 1.08B 457.31M 2024-12
Medical Developments International AUD 62.53M 563.29K 2025-12
Nanosonics AUD 1.2B 25.43M 2025-12
Ramsay Health Care AUD 7.93B 537.83M 2025-12
ResMed USD 47.56B 4.96B 2026-03
Sigma Healthcare AUD 2.68B 2.01B 2026-09
Telix Pharmaceuticals AUD 7.81B 2.74B 2026-06